Skip to main content
OpenTrials

Clinical trial condition

Relapsing Multiple Sclerosis

Explore clinical trials studying Relapsing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

68 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Multiple Sclerosis trial results

Completed

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

NCT01199861

Conditions
Relapsing Multiple Sclerosis
Locations
  • Novartis Investigative Site Aalst, Belgium
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Liège, Belgium
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)

NCT07211633

Conditions
Relapsing Multiple Sclerosis
Locations
  • TG Therapeutics Investigational Trial Site Banja Luka, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Bihać, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Mostar, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Saravejo, Bosnia and Herzegovina
View all 48 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

NCT07483450

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University First Hospital Beijing, China
  • Beijing Hospital of Ministry of Health Beijing, China
View all 17 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT05156281

Conditions
Charcot-Marie-Tooth disease, Type 1F, Disease Attributes, Pathologic Processes, +3 more
Locations
  • Ctr for Neurology and Spine Phoenix, Arizona, United States
  • Vladimir Royter MD APMC Hanford, California, United States
  • VA Greater LA Healthcare System Los Angeles, California, United States
  • Regina Berkovich MD PhD Inc West Hollywood, California, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

NCT04586023

Conditions
Relapsing Multiple Sclerosis
Locations
  • North Central Neurology Associates Cullman, Alabama, United States
  • Xenoscience Phoenix, Arizona, United States
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Torrance, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Effects of Ocrevus in Relapsing Multiple Sclerosis

NCT04387734

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Georgia State University Atlanta, Georgia, United States
  • Multiple Sclerosis Center of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

NCT06847724

Conditions
Relapsing Multiple Sclerosis
Locations
  • Sandoz Investigational Site Maitland, Florida, United States
  • Sandoz Investigational Site Ormond Beach, Florida, United States
  • Sandoz Investigational Site Banja Luka, Bosnia and Herzegovina
  • Sandoz Investigational Site Bihać, Bosnia and Herzegovina
View all 41 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT05147220

Conditions
Charcot-Marie-Tooth disease, Type 1F, Disease Attributes, Pathologic Processes, +3 more
Locations
  • AZ Integrated Neuro and Spine Phoenix, Arizona, United States
  • Center for Neurosciences Tucson, Arizona, United States
  • The Belinga Clinic Fort Smith, Arkansas, United States
  • The Research and Education Inst of Alta Bates Summit Med Grp Berkeley, California, United States
View all 199 locations
View Trial Details

Related conditions